Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNM1 | Q05193 | 10/20 | 0.77 |
| ▸ | HTT | P42858 | 2/20 | 0.71 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.55 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.53 |
| ▸ | HSP90AA1 | P07900 | 2/20 | 0.52 |
| ▸ | RAD52 | P43351 | 2/20 | 0.52 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.48 |
| ▸ | ATG4B | Q9Y4P1 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1292726 | 0.96 | DNM1 (0.81) | DNM1HTTKMT2ASLC22A1HSP90AA1 | |
| Fluoride Ion SCHEMBL26978397 | 0.93 | DNM1 (0.77) | DNM1HTTKMT2ASLC22A1HSP90AA1 | |
| Bromide SCHEMBL5091325 | 0.93 | DNM1 (0.82) | DNM1HTTKMT2ASLC22A1HSP90AA1 | |
| Iodide SCHEMBL5092215 | 0.93 | DNM1 (0.77) | DNM1HTTKMT2ASLC22A1HSP90AA1 | |
| SCHEMBL9935074 | 0.93 | DNM1 (0.77) | DNM1HTTKMT2ASLC22A1HSP90AA1 | |
| Hydrochloric Acid SCHEMBL667778 | 0.93 | DNM1 (0.77) | DNM1HTTKMT2ASLC22A1HSP90AA1 | |
| SCHEMBL10002127 | 0.93 | DNM1 (0.88) | DNM1HTTKMT2ASLC22A1HSP90AA1 | |
| Water SCHEMBL1333603 | 0.93 | DNM1 (0.77) | DNM1HTTKMT2ASLC22A1HSP90AA1 | |
| SCHEMBL33567 | 0.91 | DNM1 (0.65) | DNM1HTTKMT2AHSP90AA1RAD52 | |
| SCHEMBL16132993 | 0.90 | DNM1 (0.94) | DNM1HTTKMT2ASLC22A1HSP90AA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8546609-B2 | Ionic liquid containing allylsulfonate anion | WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) | 2013-10-01 | — | — | US | disclosed |
| EP-2474527-A1 | IONIC LIQUID CONTAINING ALLYLSULFONATE ANION | Wako Pure Chemical Industries, Ltd. (JP) | 2012-07-11 | — | — | EP | disclosed |
| US-20120157680-A1 | IONIC LIQUID CONTAINING ALLYLSULFONATE ANION | WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) | 2012-06-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120157680-A1 | IONIC LIQUID CONTAINING ALLYLSULFONATE ANION | ATXN2L, ARL1, INPPL1 | DNM1 3583/4885HTT 3354/4885KMT2A 4633/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.